Recent research has found that PD-L1 expression measured by immunohistochemistry (IHC) and TMB measured by whole exome sequencing (WES) are not reliable predictors of ICB response in a variety of tumor types (McGrail, Pilié, Rashid, Voorwerk, Slagter, Kok, et al). This evidence concerns the gene CD274 and neoplasm.